TRAVATAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Travatan, and what generic alternatives are available?
Travatan is a drug marketed by Alcon Pharms Ltd and Sandoz and is included in two NDAs. There are three patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in TRAVATAN is travoprost. There are fifteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the travoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Travatan
A generic version of TRAVATAN was approved as travoprost by CHARTWELL RX on March 1st, 2013.
Paragraph IV (Patent) Challenges for TRAVATAN
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| TRAVATAN | Ophthalmic Solution | travoprost | 0.004% | 021257 | 1 | 2008-11-28 |
US Patents and Regulatory Information for TRAVATAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT2 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT2 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | AT2 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TRAVATAN
See the table below for patents covering TRAVATAN around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Luxembourg | 92058 | ⤷ Start Trial | |
| South Korea | 20010021835 | ⤷ Start Trial | |
| Australia | 690120 | ⤷ Start Trial | |
| Slovenia | 0639563 | ⤷ Start Trial | |
| European Patent Office | 1920764 | Ester isopropylique de fluprosténol dans le traitement du glaucome et de l'hypertension oculaire (Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension) | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 0003736 | ⤷ Start Trial | |
| Canada | 2181172 | COMPOSITIONS DE PROSTAGLANDINE STABLES AU STOCKAGE (STORAGE-STABLE PROSTAGLANDIN COMPOSITIONS) | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TRAVATAN
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1514548 | CA 2014 00038 | Denmark | ⤷ Start Trial | PRODUCT NAME: TRAVOPROST; REG. NO/DATE: EU/1/01/199/001-002 20011127 |
| 1920764 | SPC/GB12/038 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129 |
| 1920764 | 2012/033 | Ireland | ⤷ Start Trial | PRODUCT NAME: TRAVOPROST (ALSO CALLED FLUPROSTENOL ISOPROPYL ESTER); NAT REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; FIRST REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; PAEDIATRIC INVESTIGATION PLAN: P/0298/2013 PROCEEDINGS UNDER SECTION 37 OF THE PATENTS ACT, 1992 RESTORATION ORDER DATED 12TH JANUARY 2016, WAS MADE RESTORING THE PATENT MENTIONED BELOW S85583 PAUL DOYLE A RE-USABLE BAG SYSTEM RESTORATION ORDERS DATED 16TH FEBRUARY 2016, WERE MADE RESTORING THE PATENTS MENTIONED BELOW S86133 MERVYN GREENE MULTI PURPOSE TANK STAND WITH COMPLEX LOCKING MECHANISM 86119 MPC GREEN LIMITED ANEW BIN |
| 1920764 | 12C0045 | France | ⤷ Start Trial | PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001 20011127 |
| 1514548 | PA2014029 | Lithuania | ⤷ Start Trial | PRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129 |
| 1920764 | 92058 | Luxembourg | ⤷ Start Trial | 92058, EXPIRES: 20161127 |
| 1920764 | C300540 | Netherlands | ⤷ Start Trial | PRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001-002 20011127 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Investment Scenario, Market Dynamics, and Financial Trajectory for TRAVATAN (Bimatoprost)
More… ↓
